• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Fostering MOUD use in justice populations: Assessing the comparative effectiveness of two favored implementation strategies to increase MOUD use.促进司法人群使用美沙酮维持治疗:评估两种增加美沙酮维持治疗使用的首选实施策略的相对效果。
J Subst Abuse Treat. 2021 Sep;128:108370. doi: 10.1016/j.jsat.2021.108370. Epub 2021 Mar 17.
2
Massachusetts Justice Community Opioid Innovation Network (MassJCOIN).马萨诸塞州司法社区阿片类药物创新网络(MassJCOIN)。
J Subst Abuse Treat. 2021 Sep;128:108275. doi: 10.1016/j.jsat.2021.108275. Epub 2021 Jan 8.
3
A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System.《在刑事司法系统中实施治疗阿片类药物使用障碍药物的障碍和促进因素的范围综述》。
Int J Drug Policy. 2020 Jul;81:102768. doi: 10.1016/j.drugpo.2020.102768. Epub 2020 May 20.
4
The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail.转衔诊所网络:监禁后成瘾治疗、医疗保健和社会支持(TCN-PATHS):一种增强初级保健的混合 1 型有效性试验,旨在改善从监狱获释后的阿片类药物使用障碍治疗结果。
J Subst Abuse Treat. 2021 Sep;128:108315. doi: 10.1016/j.jsat.2021.108315. Epub 2021 Jan 29.
5
Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.招募农村初级保健提供者以实施专注于阿片类药物使用障碍药物治疗(MOUD)的综合护理模式的策略。
Implement Res Pract. 2023 Feb 19;4:26334895231152808. doi: 10.1177/26334895231152808. eCollection 2023 Jan-Dec.
6
Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative.监禁环境下阿片类药物使用障碍治疗在保释改革时代:一项州范围药物治疗计划实施的障碍和促进因素的定性研究。
Addict Sci Clin Pract. 2022 Jun 2;17(1):30. doi: 10.1186/s13722-022-00313-6.
7
Use of Project ECHO to promote evidence based care for justice involved adults with opioid use disorder.利用 ECHO 项目促进基于证据的护理,以满足涉及阿片类药物使用障碍的成年罪犯的需求。
Subst Abus. 2022;43(1):336-343. doi: 10.1080/08897077.2021.1941518. Epub 2021 Jul 20.
8
Availability of best practices for opioid use disorder in jails and related training and resource needs: findings from a national interview study of jails in heavily impacted counties in the U.S.美国受影响严重的县监狱中阿片类药物使用障碍最佳实践的可用性以及相关培训和资源需求:一项全国监狱访谈研究的结果
Health Justice. 2022 Dec 20;10(1):36. doi: 10.1186/s40352-022-00197-3.
9
Kentucky Women's Justice Community Opioid Innovation Network (JCOIN): A type 1 effectiveness-implementation hybrid trial to increase utilization of medications for opioid use disorder among justice-involved women.肯塔基州妇女司法社区阿片类药物创新网络(JCOIN):一项旨在提高涉及司法的女性中阿片类药物使用障碍药物治疗利用率的 1 型有效性-实施混合试验。
J Subst Abuse Treat. 2021 Sep;128:108284. doi: 10.1016/j.jsat.2021.108284. Epub 2021 Jan 9.
10
An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated.对被监禁者阿片类药物使用障碍(MOUD)药物治疗的伦理分析。
Subst Abus. 2020;41(2):150-154. doi: 10.1080/08897077.2019.1695706. Epub 2019 Dec 4.

引用本文的文献

1
A mixed-method exploratory assessment of provider-based stigma of opioid use disorder (OUD) and support for medications for opioid use disorder (MOUD) in carceral settings.对监狱环境中基于提供者的阿片类药物使用障碍(OUD)污名化以及对阿片类药物使用障碍药物治疗(MOUD)支持情况的混合方法探索性评估。
Harm Reduct J. 2025 Aug 18;22(1):141. doi: 10.1186/s12954-025-01291-z.
2
The wide-angle lens of implementation science to improve health outcomes in criminal legal settings.实施科学的广角镜头,以改善刑事法律环境中的健康结果。
Health Justice. 2025 Mar 11;13(1):14. doi: 10.1186/s40352-025-00323-x.
3
A conceptual framework for assessing implementation strategy integrity.评估实施策略完整性的概念框架。
Implement Res Pract. 2024 Dec 5;5:26334895241297278. doi: 10.1177/26334895241297278. eCollection 2024 Jan-Dec.
4
Access to medications for opioid use disorder for formerly incarcerated individuals during community reentry: a mini narrative review.曾服刑人员在社区重返社会期间获得阿片类药物使用障碍治疗药物的机会:小型叙事性综述。
Front Public Health. 2024 May 13;12:1377193. doi: 10.3389/fpubh.2024.1377193. eCollection 2024.
5
The association between attitudes and the provision of medications for opioid use disorder (MOUD) in United States jails.美国监狱中态度与阿片类药物使用障碍药物治疗(MOUD)供应之间的关联。
Drug Alcohol Depend Rep. 2023 Dec 14;10:100211. doi: 10.1016/j.dadr.2023.100211. eCollection 2024 Mar.
6
Sociodemographic differences in quality of treatment to Medicaid enrollees receiving buprenorphine.接受丁丙诺啡治疗的医疗补助受种者的治疗质量在社会人口统计学方面的差异。
Subst Abus. 2022 Dec;43(1):1057-1071. doi: 10.1080/08897077.2022.2060424.
7
Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder.长效丁丙诺啡的相关影响因素:阿片类物质使用障碍的在押患者与非在押患者的比较
Patient Prefer Adherence. 2021 Jun 14;15:1259-1267. doi: 10.2147/PPA.S311674. eCollection 2021.

本文引用的文献

1
A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System.《在刑事司法系统中实施治疗阿片类药物使用障碍药物的障碍和促进因素的范围综述》。
Int J Drug Policy. 2020 Jul;81:102768. doi: 10.1016/j.drugpo.2020.102768. Epub 2020 May 20.
2
Advancing the implementation and sustainment of medication assisted treatment for opioid use disorders in prisons and jails.推进监狱中阿片类物质使用障碍药物辅助治疗的实施与持续开展。
Health Justice. 2019 Dec 12;7(1):19. doi: 10.1186/s40352-019-0100-2.
3
Brief video intervention to improve attitudes throughout medications for opioid use disorder in a correctional setting.简短的视频干预措施可改善监管场所阿片类药物使用障碍药物治疗期间的态度。
J Subst Abuse Treat. 2019 Sep;104:28-33. doi: 10.1016/j.jsat.2019.06.001. Epub 2019 Jun 10.
4
Project ECHO (Extension for Community Healthcare Outcomes): A new model for educating primary care providers about treatment of substance use disorders.社区医疗成果推广计划(ECHO):一种针对初级保健提供者开展物质使用障碍治疗教育的新模式。
Subst Abus. 2016;37(1):20-4. doi: 10.1080/08897077.2015.1129388.
5
Implementation Science in School Mental Health: Key Constructs in a Developing Research Agenda.学校心理健康中的实施科学:发展研究议程中的关键构建要素
School Ment Health. 2014 May 1;6(2):99-111. doi: 10.1007/s12310-013-9115-3.
6
Depression Anxiety Stress Scales-21: measurement and structural invariance across ratings of men and women.抑郁焦虑压力量表-21:男性和女性评分中的测量与结构不变性
Assessment. 2014 Aug;21(4):418-26. doi: 10.1177/1073191113514106. Epub 2014 Jan 31.
7
Testing use of payers to facilitate evidence-based practice adoption: protocol for a cluster-randomized trial.利用支付方促进基于证据的实践采用的测试:一项群组随机试验方案。
Implement Sci. 2013 May 10;8:50. doi: 10.1186/1748-5908-8-50.
8
Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions.刑事司法机构中与刑事司法-药物滥用治疗研究(CJ-DATS)相关的药物辅助治疗:可及性、障碍和意图。
Subst Abus. 2012;33(1):9-18. doi: 10.1080/08897077.2011.611460.
9
Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey.美国监狱系统中美沙酮和丁丙诺啡的处方及转诊实践:一项全国性调查的结果
Drug Alcohol Depend. 2009 Nov 1;105(1-2):83-8. doi: 10.1016/j.drugalcdep.2009.06.015. Epub 2009 Jul 21.
10
The National Criminal Justice Treatment Practices survey: multilevel survey methods and procedures.《国家刑事司法治疗实践调查:多层次调查方法与程序》
J Subst Abuse Treat. 2007 Apr;32(3):225-38. doi: 10.1016/j.jsat.2007.01.002. Epub 2007 Mar 9.

促进司法人群使用美沙酮维持治疗:评估两种增加美沙酮维持治疗使用的首选实施策略的相对效果。

Fostering MOUD use in justice populations: Assessing the comparative effectiveness of two favored implementation strategies to increase MOUD use.

机构信息

University of Wisconsin, United States of America.

University of Wisconsin, United States of America.

出版信息

J Subst Abuse Treat. 2021 Sep;128:108370. doi: 10.1016/j.jsat.2021.108370. Epub 2021 Mar 17.

DOI:10.1016/j.jsat.2021.108370
PMID:33762145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8384644/
Abstract

Coaching is a favored strategy for the implementation of medications for opioid use disorder (MOUD), yet research has not adequately tested or assessed coaching dosages and mediums for overall effectiveness, nor have coaching doses been widely studied within criminal justice settings (CJS). Scaling up the use of MOUD, particularly in CJS, presents a challenge given the stigmatization of substance use disorder, funding for MOUD, availability and capacity of community-based treatment providers, leadership support, and the historical preference for behavioral therapy-based treatment practices. The University of Wisconsin's Center for Health Enhancement and Systems Studies (CHESS) and George Mason University's Center for Advancing Correctional Excellence! (ACE!) are conducting a randomized controlled trial to determine the optimal combination and dosages for two different coaching strategies to disseminate MOUD in justice-involved populations; those strategies are the NIATx model for process improvement and Extension for Community Healthcare Outcomes (ECHO) model. NIATx coaches provide technical assistance in MOUD implementation and organizational change to help justice and treatment organizations to implement and disseminate MOUD for justice clients. The ECHO platform focuses primarily on the clinical provider by connecting the provider with expert MOUD prescribers to promote high-quality MOUD practices. The trial will have four study arms that compare high-dose and low-dose coaching, with and without ECHO. This will be the first trial that assesses the comparative effectiveness of two types of coaching methods at varying dosages for justice-involved individuals. The trial will be conducted with 48 jails and community-based treatment provider sites that handle justice-involved persons with opioid use disorder (OUD).

摘要

辅导是实施阿片类药物使用障碍(MOUD)药物的首选策略,但研究尚未充分测试或评估辅导剂量和总体效果的媒介,也没有在刑事司法环境(CJS)中广泛研究辅导剂量。鉴于物质使用障碍的污名化、MOUD 的资金、基于社区的治疗提供者的可用性和能力、领导力支持以及对基于行为疗法的治疗实践的历史偏好,扩大 MOUD 的使用,特别是在 CJS 中,是一个挑战。威斯康星大学健康增强和系统研究中心(CHESS)和乔治梅森大学矫正卓越中心(ACE!)正在进行一项随机对照试验,以确定两种不同辅导策略的最佳组合和剂量,以在涉及司法的人群中传播 MOUD;这些策略是用于过程改进的 NIATx 模型和扩展社区医疗保健成果(ECHO)模型。NIATx 教练在 MOUD 实施和组织变革方面提供技术援助,以帮助司法和治疗组织为司法客户实施和传播 MOUD。ECHO 平台主要侧重于临床提供者,通过将提供者与专家 MOUD 处方提供者联系起来,促进高质量的 MOUD 实践。该试验将有四个研究臂,比较高剂量和低剂量的辅导,有和没有 ECHO。这将是第一个评估两种类型的辅导方法在不同剂量下对涉及司法的个体的比较效果的试验。该试验将在 48 个监狱和处理涉及司法的阿片类药物使用障碍(OUD)人员的基于社区的治疗提供者场所进行。